...
机译:在日常练习护理中携带的牛皮制,涅安普(Etanercept和Ustekukumab)的幸福药物存活:来自Biocapture Network的结果
Department of Dermatology Radboud University Medical CenterNijmegen Netherlands;
Department of Dermatology Radboud University Medical CenterNijmegen Netherlands;
Department for Health Evidence Radboud University Medical CenterNijmegen Netherlands;
Department of Dermatology Radboud University Medical CenterNijmegen Netherlands;
Department of Dermatology Radboud University Medical CenterNijmegen Netherlands;
Department of Dermatology Radboud University Medical CenterNijmegen Netherlands;
Department of Dermatology Hospital Group Twente (ZGT)Almelo/Hengelo Netherlands;
Department of Dermatology Hospital Group Twente (ZGT)Almelo/Hengelo Netherlands;
Department of Dermatology St. Anna HospitalZiekenhuis Geldrop Netherlands;
Department of Dermatology Gelre HospitalApeldoorn Netherlands;
Department of Dermatology Gelderse Vallei Hospital (ZGV)Ede Netherlands;
Department of Dermatology Slingeland HospitalDoetinchem Netherlands;
Department of Dermatology Máxima Medical Center (MMC)Eindhoven/Veldhoven Netherlands;
Department of Dermatology Jeroen Bosch Hospital (JBZ)'s-Hertogenbosch Netherlands;
Department of Dermatology Radboud University Medical CenterNijmegen Netherlands;
Department of Dermatology Radboud University Medical CenterNijmegen Netherlands;
Department of Dermatology Radboud University Medical CenterNijmegen Netherlands;
机译:日常实践中阿达木单抗,依那西普和ustekinumab在牛皮癣中的快乐药物存活率:BioCAPTURE网络的结果
机译:在日常练习护理中携带的牛皮制,涅安普(Etanercept和Ustekukumab)的幸福药物存活:来自Biocapture Network的结果
机译:体重指数预测因无效而终止治疗,女性预测日常使用阿达木单抗,依那西普或乌斯替单抗治疗的牛皮癣患者因副作用而终止治疗:BioCAPTURE注册中心的一项前瞻性,比较性,长期药物生存研究
机译:院前创伤护理中药物管理实践的智能教育环境:工程与医学职业之间的多学科经验
机译:鉴定和表征与癌症生存和药物滥用相关的基因和微小RNA网络。
机译:在AdaNerimumab依赖替替尼单抗或Ustekuinab上的低疾病活动患者的牛皮癣患者未满足的人身患者
机译:常规实验室参数动力学和 银屑病患者长期实验室不良事件 用阿达木单抗,依那西普和Ustekinumab治疗
机译:工作场所解决方案:通过日常实践做好准备:医疗保健中呼吸保护的神话。